Octavio Espinoza - Oct 1, 2023 Form 4 Insider Report for LIGAND PHARMACEUTICALS INC (LGND)

Role
Chief Financial Officer
Signature
By: /s/ Andrew Reardon For: Octavio Espinoza
Stock symbol
LGND
Transactions as of
Oct 1, 2023
Transactions value $
-$20,732
Form type
4
Date filed
10/3/2023, 04:36 PM
Previous filing
Jul 10, 2023
Next filing
Dec 6, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LGND Common Stock Tax liability -$20.7K -346 -1.41% $59.92 24.2K Oct 1, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares withheld by the Issuer in payment of the tax liability arising in connection with the settlement of restricted stock units.